Financials in USD. Standardized financial statements.
A compact view of how Theralink Technologies, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $606,796 | $567,905 | $505,604 | $181,229 | $0 | $0 | $0 | $0 | $74 | $254 |
| Revenue Growth? | +6.8% | +12.3% | +179.0% | 0.0% | 0.0% | 0.0% | 0.0% | -100.0% | -70.9% | 0.0% |
| Cost of Revenue? | $126,237 | $224,886 | $117,456 | $52,587 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit? | $480,559 | $343,019 | $388,148 | $128,642 | $0 | $0 | $0 | $0 | $74 | $254 |
| Gross Margin? | +79.2% | +60.4% | +76.8% | +71.0% | 0.0% | 0.0% | 0.0% | 0.0% | +100.0% | +100.0% |
| Operating Expenses? | $9.22M | $11.98M | $5.95M | $3.49M | $1.77M | $1.78M | $2.46M | $1.80M | $807,645 | $452,698 |
| Operating Income? | -$8.98M | -$11.64M | -$5.57M | -$3.36M | -$1.77M | -$1.78M | -$2.46M | -$1.80M | -$807,645 | -$452,444 |
| EBITDA? | -$8.73M | -$11.45M | -$5.38M | -$3.25M | -$1.77M | -$1.78M | -$2.46M | -$1.80M | -$807,371 | -$452,444 |
| Income Before Tax | -$30.91M | -$12.74M | -$5.47M | -$3.17M | -$9.40M | $6.47M | -$14.85M | -$2.01M | -$990,396 | -$453,879 |
| Income Tax Expense | $16.71M | $7,300 | $121,094 | $41,218 | $1.80M | -$10.38M | $16.90M | $101,516 | $180,272 | -$554 |
| Net Income? | -$30.91M | -$12.75M | -$5.59M | -$3.21M | -$11.20M | $6.47M | -$20.51M | -$2.01M | -$990,396 | -$453,879 |
| EPS? | $-0.50 | $-0.22 | $-0.10 | $-3.79 | $-22.63 | $20.74 | $-119.37 | $-25.91 | $-15.08 | $-13.92 |
| Diluted EPS? | $-0.01 | $-0.00 | $-0.00 | $-0.00 | $-22.63 | $9.13 | $-119.37 | $-25.91 | $-15.08 | $-13.92 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality